These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
|
95-3359658
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
One Park Place, Suite 600, Dublin, CA
|
|
94568
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
|
|
Large accelerated filer
|
x
|
Accelerated filer
|
o
|
|
|
|
|
|
|
Non-accelerated filer
|
o
|
Smaller reporting company
|
o
|
|
|
|
|
|
|
|
|
Emerging growth company
|
o
|
|
|
|
|
Form 10-Q
Cross Reference
|
Page
|
|
|
||
|
Part I, Item 1.
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
Part I, Item 2.
|
||
|
Part I, Item 3.
|
||
|
Part I, Item 4.
|
||
|
Part II, Item 1.
|
||
|
Part II, Item 1A.
|
||
|
Part II, Item 2.
|
||
|
Part II, Item 3.
|
||
|
Part II, Item 4.
|
||
|
Part II, Item 5.
|
||
|
Part II, Item 6.
|
||
|
GLOSSARY
|
|
|
AFS
|
Available-for-sale
|
|
ASC
|
Accounting standards codification
|
|
ASU
|
Accounting standards update
|
|
CEO
|
Chief Executive Officer
|
|
CFO
|
Chief Financial Officer
|
|
COPS
|
Cost of providing services
|
|
D&A
|
Depreciation and Amortization
|
|
EBITDA
|
Earnings before interest expense, taxes, depreciation and amortization of intangible assets
|
|
EPS
|
Earnings Per Share
|
|
ERISA
|
Employee Retirement Income Security Act of 1974
|
|
FASB
|
Financial Accounting Standards Board
|
|
G&A
|
General and administrative
|
|
GAAP
|
Generally Accepted Accounting Principles in the United States
|
|
HR
|
Human Resources
|
|
IRS
|
Internal Revenue Service
|
|
ISR
|
Insurance service revenues
|
|
MD&A
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
|
NISR
|
Net Insurance Service Revenues
|
|
NSR
|
Net service revenues
|
|
OE
|
Operating expenses
|
|
PFC
|
Payroll funds collected
|
|
PSR
|
Professional service revenues
|
|
ROU
|
Right-of-use
|
|
RSA
|
Restricted Stock Award
|
|
RSU
|
Restricted Stock Unit
|
|
SBC
|
Stock Based Compensation
|
|
S&M
|
Sales and marketing
|
|
SD&P
|
Systems development and programming
|
|
SEC
|
Securities and Exchange Commission
|
|
SMB
|
Small to midsize business
|
|
U.S.
|
United States
|
|
WSE
|
Worksite employee
|
|
|
|
|
|
FORWARD LOOKING STATEMENTS AND OTHER FINANCIAL INFORMATION
|
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
•
|
we benefited from our clients growing their WSEs,
|
|
•
|
our customers increased their participation, or enrollment in our insurance services offerings, and
|
|
•
|
we delivered profitable growth.
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
$934M
|
|
$82M
|
|
$251M
|
||||||
|
|
Total revenues
|
|
Operating income
|
|
Net Service Revenue *
|
||||||
|
|
9
|
%
|
increase
|
|
17
|
%
|
increase
|
|
14
|
%
|
increase
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
$63M
|
|
$0.89
|
|
$69M
|
||||||
|
|
Net income
|
|
Diluted EPS
|
|
Adjusted Net income *
|
||||||
|
|
17
|
%
|
increase
|
|
19
|
%
|
increase
|
|
20
|
%
|
increase
|
|
|
|
|
|
|
|
|
|
|
|||
|
*
|
Non-GAAP measure as defined in the section below.
|
|
|
|
|
||||||
|
|
316,906
|
|
312,760
|
|
$11.6B
|
||||||
|
|
Total WSE
|
|
Average WSE
|
|
Payroll and payroll tax payments
|
||||||
|
|
—
|
%
|
flat
|
|
(1
|
)%
|
decrease
|
|
13
|
%
|
increase
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
|
Three Months Ended March 31,
|
||||||||||
|
(in millions, except per share and WSE data)
|
|
2019
|
|
2018
|
|
% Change
|
||||||
|
Income Statement Data:
|
|
|
|
|
|
|
|
|||||
|
Total revenues
|
|
$
|
934
|
|
|
$
|
861
|
|
|
9
|
|
%
|
|
Operating income
|
|
82
|
|
|
71
|
|
|
17
|
|
|
||
|
Net income
|
|
63
|
|
|
54
|
|
|
17
|
|
|
||
|
Diluted net income per share of common stock
|
|
0.89
|
|
|
0.75
|
|
|
19
|
|
|
||
|
Non-GAAP measures
(1)
:
|
|
|
|
|
|
|
|
|||||
|
Net Service Revenues
|
|
251
|
|
|
220
|
|
|
14
|
|
|
||
|
Net Insurance Service Revenues
|
|
115
|
|
|
91
|
|
|
26
|
|
|
||
|
Adjusted EBITDA
|
|
108
|
|
|
91
|
|
|
18
|
|
|
||
|
Adjusted Net Income
|
|
69
|
|
|
58
|
|
|
20
|
|
|
||
|
|
|
|
|
|
|
|
|
|||||
|
Operating Metrics:
|
|
|
|
|
|
|
|
|||||
|
Average WSEs
|
|
312,760
|
|
|
314,561
|
|
|
(1
|
)
|
|
||
|
Total WSEs at period end
|
|
316,906
|
|
|
316,715
|
|
|
—
|
|
|
||
|
(in millions)
|
March 31,
2019 |
|
December 31,
2018 |
|
% Change
|
|
|||||
|
Balance Sheet Data:
|
|
|
|
|
|
|
|||||
|
Cash and cash equivalents
|
$
|
251
|
|
|
$
|
228
|
|
|
10
|
|
%
|
|
Working capital
|
226
|
|
|
221
|
|
|
2
|
|
|
||
|
Total assets
|
2,345
|
|
|
2,435
|
|
|
(4
|
)
|
|
||
|
Long-term debt
|
407
|
|
|
413
|
|
|
(1
|
)
|
|
||
|
Total liabilities
|
1,939
|
|
|
2,060
|
|
|
(6
|
)
|
|
||
|
Total stockholders’ equity
|
406
|
|
|
375
|
|
|
8
|
|
|
||
|
|
Three Months Ended March 31,
|
|||||||||||
|
(in millions)
|
2019
|
|
2018
|
|
% Change
|
|||||||
|
Cash Flow Data:
|
|
|
|
|
|
|
||||||
|
Net cash used in operating activities
|
$
|
(142
|
)
|
|
$
|
(536
|
)
|
|
(73
|
)
|
%
|
|
|
Net cash (used in) provided by investing activities
|
(11
|
)
|
|
2
|
|
|
(661
|
)
|
|
|||
|
Net cash used in financing activities
|
(47
|
)
|
|
(19
|
)
|
|
145
|
|
|
|||
|
Non-GAAP measure
(1)
:
|
|
|
|
|
|
|
||||||
|
Corporate operating cash flows
|
78
|
|
|
45
|
|
169
|
|
73
|
|
|
||
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
Non-GAAP Measure
|
Definition
|
How We Use The Measure
|
|
Net Service Revenues
|
• Sum of professional service revenues and Net Insurance Service Revenues,
or total revenues less insurance costs. |
• Provides a comparable basis of revenues on a net basis. Professional service revenues are presented net of client payroll costs whereas insurance service revenues are presented gross of insurance costs for financial reporting purposes.
• Acts as the basis to allocate resources to different functions and evaluates the effectiveness of our business strategies by each business function. • Provides a measure, among others, used in the determination of incentive compensation for management. |
|
Net Insurance Service Revenues
|
• Insurance revenues less insurance costs.
|
• Is a component of Net Service Revenues.
• Provides a comparable basis of revenues on a net basis. Professional service revenues are presented net of client payroll costs whereas insurance service revenues are presented gross of insurance costs for financial reporting purposes. Promotes an understanding of our insurance services business by evaluating insurance service revenues net of our WSE related costs which are substantially pass-through for the benefit of our WSEs. Under GAAP, insurance service revenues and costs are recorded gross as we have latitude in establishing the price, service and supplier specifications.
• We also sometimes refer to Net Insurance Service Margin, which is the ratio of Net Insurance Revenue to Insurance Service Revenue.
|
|
Adjusted EBITDA
|
• Net income, excluding the effects of:
- income tax provision,
- interest expense,
- depreciation,
- amortization of intangible assets, and
- stock-based compensation expense.
|
• Provides period-to-period comparisons on a consistent basis and an understanding as to how our management evaluates the effectiveness of our business strategies by excluding certain non-cash charges such as depreciation and amortization, and stock-based compensation recognized based on the estimated fair values. We believe these charges are either not directly resulting from our core operations or not indicative of our ongoing operations.
• Enhances comparisons to prior periods and, accordingly, facilitates the development of future projections and earnings growth prospects.
• Provides a measure, among others, used in the determination of incentive compensation for management.
• We also sometimes refer to Adjusted EBITDA margin, which is the ratio of Adjusted EBITDA to Net Service Revenue.
|
|
Adjusted Net Income
|
• Net income, excluding the effects of:
- effective income tax rate
(1)
,
- stock-based compensation,
- amortization of intangible assets,
- non-cash interest expense
(2)
, and
- the income tax effect (at our effective tax rate
(1)
) of these pre-tax adjustments.
|
• Provides information to our stockholders and board of directors to understand how our management evaluates our business, to monitor and evaluate our operating results, and analyze profitability of our ongoing operations and trends on a consistent basis by excluding certain non-cash charges.
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
Corporate Operating Cash Flows
|
• Net cash (used in) provided by operating activities, excluding the effects of:
- Assets associated with WSEs (accounts receivable, unbilled revenue, prepaid expenses and other current assets) and
- Liabilities associated with WSEs (client deposits, accrued wages, payroll tax liabilities and other payroll withholdings, accrued health benefit costs, accrued workers' compensation costs, insurance premiums and other payables, and other current liabilities).
|
• Provides information that our stockholders and management can use to evaluate our cash flows from operations independent of the current assets and liabilities associated with our WSEs.
• Enhances comparisons to prior periods and, accordingly, used as a liquidity measure to manage liquidity between corporate and WSE related activities, and to help determine and plan our cash flow and capital strategies.
|
|
(1)
|
Non-GAAP effective tax rate is
26%
for
2019
and
2018
, which excludes the income tax impact from stock-based compensation, changes in uncertain tax positions, and nonrecurring benefits or expenses from federal legislative changes.
|
|
(2)
|
Non-cash interest expense represents amortization and write-off of our debt issuance costs.
|
|
|
Three Months Ended March 31,
|
|||||
|
(in millions)
|
2019
|
2018
|
||||
|
Total revenues
|
$
|
934
|
|
$
|
861
|
|
|
Less: Insurance costs
|
683
|
|
641
|
|
||
|
Net Service Revenues
|
$
|
251
|
|
$
|
220
|
|
|
|
Three Months Ended March 31,
|
|||||
|
(in millions)
|
2019
|
2018
|
||||
|
Insurance service revenues
|
$
|
798
|
|
$
|
732
|
|
|
Less: Insurance costs
|
683
|
|
641
|
|
||
|
Net Insurance Service Revenues
|
$
|
115
|
|
$
|
91
|
|
|
Net Insurance Service Revenue Margin
|
14
|
%
|
12
|
%
|
||
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
Three Months Ended March 31,
|
|||||
|
(in millions)
|
2019
|
2018
|
||||
|
Net income
|
$
|
63
|
|
$
|
54
|
|
|
Provision for income taxes
|
20
|
|
13
|
|
||
|
Stock-based compensation
|
9
|
|
9
|
|
||
|
Interest expense and bank fees
|
5
|
|
6
|
|
||
|
Depreciation and amortization of intangible assets
|
11
|
|
9
|
|
||
|
Adjusted EBITDA
|
$
|
108
|
|
$
|
91
|
|
|
Adjusted EBITDA Margin
|
43
|
%
|
41
|
%
|
||
|
|
Three Months Ended March 31,
|
|||||
|
(in millions)
|
2019
|
2018
|
||||
|
Net income
|
$
|
63
|
|
$
|
54
|
|
|
Effective income tax rate adjustment
|
(1
|
)
|
(4
|
)
|
||
|
Stock-based compensation
|
9
|
|
9
|
|
||
|
Amortization of intangible assets
|
1
|
|
1
|
|
||
|
Non-cash interest expense
|
—
|
|
1
|
|
||
|
Income tax impact of pre-tax adjustments
|
(3
|
)
|
(3
|
)
|
||
|
Adjusted Net Income
|
$
|
69
|
|
$
|
58
|
|
|
|
Three Months Ended March 31,
|
|||||
|
(in millions)
|
2019
|
2018
|
||||
|
Net cash used in operating activities
|
$
|
(142
|
)
|
$
|
(536
|
)
|
|
Change in WSE related other current assets
|
45
|
|
15
|
|
||
|
Change in WSE related liabilities
|
175
|
|
566
|
|
||
|
Corporate Operating Cash Flows
|
$
|
78
|
|
$
|
45
|
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
•
|
Volume - the percentage change in period over period Average WSEs,
|
|
•
|
Rate - the combined percentage changes in service fees for each vertical product and changes in service fees associated with each insurance service offering, and
|
|
•
|
Mix - the change in composition of Average WSEs within our verticals combined with the composition of our enrolled WSEs within our insurance offerings.
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
(in millions)
|
|
|
|
$71
|
First Quarter 2018 Operating Income
|
|
|
|
+73
|
Higher total revenues primarily as a result of an increase in ISR fees and health plan enrollment.
|
|
|
-42
|
Higher insurance costs primarily as a result of an increase in health plan participation, or enrollment.
|
|
|
-20
|
Higher OE primarily as a result of growth in the number of our corporate employees and costs associated with initiatives to improve customer experience.
|
|
$82
|
First Quarter 2019 Operating Income
|
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
•
|
Mix - the change in composition of Average WSEs within our verticals,
|
|
•
|
Rate - the percentage changes in fees for each vertical, and
|
|
•
|
Volume - the percentage change in period over period Average WSEs.
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
•
|
Volume - the percentage change in period over period Average WSEs,
|
|
•
|
Rate - the percentage changes in fees associated with each of our insurance service offerings, and
|
|
•
|
Mix - all other changes including the composition of our enrolled WSEs within our insurance service offerings (health plan enrollment).
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
•
|
Volume - the percentage change in period over period Average WSEs,
|
|
•
|
Rate - the percentage changes in cost trend associated with each of our insurance service offerings, and
|
|
•
|
Mix - all other changes including the composition of our enrolled WSEs within our insurance offerings (health plan enrollment).
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
March 31, 2019
|
December 31, 2018
|
||||||||||||||||
|
(in millions)
|
Corporate
|
WSE
|
Total
|
Corporate
|
WSE
|
Total
|
||||||||||||
|
Current assets:
|
|
|
|
|
|
|
||||||||||||
|
Cash and cash equivalents
|
$
|
251
|
|
$
|
—
|
|
$
|
251
|
|
$
|
228
|
|
$
|
—
|
|
$
|
228
|
|
|
Investments
|
56
|
|
—
|
|
56
|
|
54
|
|
—
|
|
54
|
|
||||||
|
Restricted cash, cash equivalents and investments
|
15
|
|
707
|
|
722
|
|
15
|
|
927
|
|
942
|
|
||||||
|
Other current assets
|
34
|
|
431
|
|
465
|
|
36
|
|
386
|
|
422
|
|
||||||
|
Total current assets
|
$
|
356
|
|
$
|
1,138
|
|
$
|
1,494
|
|
$
|
333
|
|
$
|
1,313
|
|
$
|
1,646
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Total current liabilities
|
$
|
130
|
|
$
|
1,138
|
|
$
|
1,268
|
|
$
|
112
|
|
$
|
1,313
|
|
$
|
1,425
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Working Capital
|
$
|
226
|
|
$
|
—
|
|
$
|
226
|
|
$
|
221
|
|
$
|
—
|
|
$
|
221
|
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
Three Months Ended March 31,
|
|||||||||||||||||
|
(in millions)
|
2019
|
2018
|
||||||||||||||||
|
|
Corporate
|
WSE
|
Total
|
Corporate
|
WSE
|
Total
|
||||||||||||
|
Net cash provided by (used in):
|
|
|
|
|
|
|
||||||||||||
|
Operating activities
|
$
|
78
|
|
$
|
(220
|
)
|
$
|
(142
|
)
|
$
|
45
|
|
$
|
(581
|
)
|
$
|
(536
|
)
|
|
Investing activities
|
(11
|
)
|
—
|
|
(11
|
)
|
2
|
|
—
|
|
2
|
|
||||||
|
Financing activities
|
(47
|
)
|
—
|
|
(47
|
)
|
(19
|
)
|
—
|
|
(19
|
)
|
||||||
|
Net increase (decrease) in cash and cash equivalents, unrestricted and restricted
|
$
|
20
|
|
$
|
(220
|
)
|
$
|
(200
|
)
|
$
|
28
|
|
$
|
(581
|
)
|
$
|
(553
|
)
|
|
Cash and cash equivalents, unrestricted and restricted:
|
|
|
|
|
|
|
||||||||||||
|
Beginning of period
|
425
|
|
924
|
|
1,349
|
|
476
|
|
1,262
|
|
1,738
|
|
||||||
|
End of period
|
$
|
445
|
|
$
|
704
|
|
$
|
1,149
|
|
$
|
504
|
|
$
|
681
|
|
$
|
1,185
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Net increase (decrease) in cash and cash equivalents:
|
|
|
|
|
|
|
||||||||||||
|
Unrestricted
|
$
|
23
|
|
$
|
—
|
|
$
|
23
|
|
$
|
(6
|
)
|
$
|
—
|
|
$
|
(6
|
)
|
|
Restricted
|
(3
|
)
|
(220
|
)
|
(223
|
)
|
34
|
|
(581
|
)
|
(547
|
)
|
||||||
|
|
Three Months Ended March 31,
|
|||||||||||||||||
|
(in millions)
|
2019
|
2018
|
||||||||||||||||
|
|
Corporate
|
WSE
|
Total
|
Corporate
|
WSE
|
Total
|
||||||||||||
|
Net income
|
$
|
63
|
|
$
|
—
|
|
$
|
63
|
|
$
|
54
|
|
$
|
—
|
|
$
|
54
|
|
|
Depreciation and amortization
|
18
|
|
—
|
|
18
|
|
10
|
|
—
|
|
10
|
|
||||||
|
Stock-based compensation expense
|
9
|
|
—
|
|
9
|
|
9
|
|
—
|
|
9
|
|
||||||
|
Interest paid
|
(4
|
)
|
—
|
|
(4
|
)
|
(4
|
)
|
—
|
|
(4
|
)
|
||||||
|
Income tax payments, net
|
(1
|
)
|
—
|
|
(1
|
)
|
—
|
|
—
|
|
—
|
|
||||||
|
Changes in other operating assets
|
(4
|
)
|
(45
|
)
|
(49
|
)
|
(2
|
)
|
(15
|
)
|
(17
|
)
|
||||||
|
Changes in other operating liabilities
|
(3
|
)
|
(175
|
)
|
(178
|
)
|
(22
|
)
|
(566
|
)
|
(588
|
)
|
||||||
|
Net cash provided by (used in) operating activities
|
$
|
78
|
|
$
|
(220
|
)
|
$
|
(142
|
)
|
$
|
45
|
|
$
|
(581
|
)
|
$
|
(536
|
)
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
Three Months Ended March 31,
|
|||||
|
(in millions)
|
2019
|
2018
|
||||
|
Investments:
|
|
|
||||
|
Purchases of investments
|
(30
|
)
|
—
|
|
||
|
Proceeds from sale and maturity of investments
|
31
|
|
14
|
|
||
|
Cash provided by investments
|
$
|
1
|
|
$
|
14
|
|
|
|
|
|
||||
|
Capital expenditures:
|
|
|
||||
|
Software and hardware
|
$
|
7
|
|
$
|
6
|
|
|
Office furniture, equipment and leasehold improvements
|
5
|
|
6
|
|
||
|
Cash used in capital expenditures
|
$
|
12
|
|
$
|
12
|
|
|
|
Three Months Ended March 31,
|
|||||
|
(in millions)
|
2019
|
2018
|
||||
|
Financing activities
|
|
|
||||
|
Repurchase of common stock, net of issuance
|
$
|
41
|
|
$
|
9
|
|
|
Repayment of borrowings
|
6
|
|
10
|
|
||
|
Cash used in financing activities
|
$
|
47
|
|
$
|
19
|
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
|
|
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
AND CONTROLS AND PROCEDURES
|
|
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
|
March 31,
|
|
December 31,
|
||||
|
(in millions, except share and per share data)
|
|
2019
|
|
2018
|
||||
|
ASSETS
|
|
|
|
|
||||
|
Current assets:
|
|
|
|
|
||||
|
Cash and cash equivalents
|
|
$
|
251
|
|
|
$
|
228
|
|
|
Investments
|
|
56
|
|
|
54
|
|
||
|
Restricted cash, cash equivalents and investments
|
|
722
|
|
|
942
|
|
||
|
Accounts receivable, net
|
|
12
|
|
|
11
|
|
||
|
Unbilled revenue, net
|
|
314
|
|
|
304
|
|
||
|
Prepaid expenses
|
|
58
|
|
|
48
|
|
||
|
Other current assets
|
|
81
|
|
|
59
|
|
||
|
Total current assets
|
|
1,494
|
|
|
1,646
|
|
||
|
Restricted cash, cash equivalents and investments, noncurrent
|
|
184
|
|
|
187
|
|
||
|
Investments, noncurrent
|
|
133
|
|
|
135
|
|
||
|
Property & equipment, net
|
|
82
|
|
|
79
|
|
||
|
Operating lease right-of-use asset
|
|
59
|
|
|
—
|
|
||
|
Goodwill
|
|
289
|
|
|
289
|
|
||
|
Other intangible assets, net
|
|
19
|
|
|
21
|
|
||
|
Other assets
|
|
85
|
|
|
78
|
|
||
|
Total assets
|
|
$
|
2,345
|
|
|
$
|
2,435
|
|
|
Liabilities and stockholders' equity
|
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
|
||||
|
Accounts payable and other current liabilities
|
|
$
|
55
|
|
|
$
|
45
|
|
|
Long-term debt
|
|
22
|
|
|
22
|
|
||
|
Client deposits
|
|
38
|
|
|
56
|
|
||
|
Accrued wages
|
|
369
|
|
|
352
|
|
||
|
Accrued health insurance costs, net
|
|
135
|
|
|
135
|
|
||
|
Accrued workers' compensation costs, net
|
|
67
|
|
|
67
|
|
||
|
Payroll tax liabilities and other payroll withholdings
|
|
550
|
|
|
729
|
|
||
|
Operating lease liabilities
|
|
16
|
|
|
—
|
|
||
|
Insurance premiums and other payables
|
|
16
|
|
|
19
|
|
||
|
Total current liabilities
|
|
1,268
|
|
|
1,425
|
|
||
|
Long-term debt, noncurrent
|
|
385
|
|
|
391
|
|
||
|
Accrued workers' compensation costs, noncurrent, net
|
|
156
|
|
|
158
|
|
||
|
Deferred taxes
|
|
65
|
|
|
68
|
|
||
|
Operating lease liabilities, noncurrent
|
|
54
|
|
|
—
|
|
||
|
Other non-current liabilities
|
|
11
|
|
|
18
|
|
||
|
Total liabilities
|
|
1,939
|
|
|
2,060
|
|
||
|
Commitments and contingencies (see Note 6)
|
|
|
|
|
||||
|
Stockholders' equity:
|
|
|
|
|
||||
|
Preferred stock
|
|
—
|
|
|
—
|
|
||
|
($0.000025 par value per share; 20,000,000 shares authorized; no shares issued or outstanding at March 31, 2019 and December 31, 2018)
|
|
|
|
|
||||
|
Common stock and additional paid-in capital
|
|
651
|
|
|
641
|
|
||
|
($0.000025 par value per share; 750,000,000 shares authorized; 70,079,747 and 70,596,559 shares issued and outstanding at March 31, 2019 and December 31, 2018)
|
|
|
|
|
||||
|
Accumulated deficit
|
|
(245
|
)
|
|
(266
|
)
|
||
|
Total stockholders' equity
|
|
406
|
|
|
375
|
|
||
|
Total liabilities & stockholders' equity
|
|
$
|
2,345
|
|
|
$
|
2,435
|
|
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
Three Months Ended March 31,
|
|||||
|
(in millions, except share and per share data)
|
2019
|
2018
|
||||
|
Professional service revenues
|
$
|
136
|
|
$
|
129
|
|
|
Insurance service revenues
|
798
|
|
732
|
|
||
|
Total revenues
|
934
|
|
861
|
|
||
|
Insurance costs
|
683
|
|
641
|
|
||
|
Cost of providing services
|
64
|
|
57
|
|
||
|
Sales and marketing
|
46
|
|
39
|
|
||
|
General and administrative
|
36
|
|
31
|
|
||
|
Systems development and programming
|
12
|
|
13
|
|
||
|
Depreciation and amortization of intangible assets
|
11
|
|
9
|
|
||
|
Total costs and operating expenses
|
852
|
|
790
|
|
||
|
Operating income
|
82
|
|
71
|
|
||
|
Other income (expense):
|
|
|
||||
|
Interest expense, bank fees and other
|
(5
|
)
|
(6
|
)
|
||
|
Interest income
|
6
|
|
2
|
|
||
|
Income before provision for income taxes
|
83
|
|
67
|
|
||
|
Income tax expense
|
20
|
|
13
|
|
||
|
Net income
|
$
|
63
|
|
$
|
54
|
|
|
Comprehensive income
|
$
|
63
|
|
$
|
54
|
|
|
|
|
|
||||
|
Net income per share:
|
|
|
||||
|
Basic
|
$
|
0.91
|
|
$
|
0.77
|
|
|
Diluted
|
$
|
0.89
|
|
$
|
0.75
|
|
|
Weighted average shares:
|
|
|
||||
|
Basic
|
69,909,984
|
|
70,047,752
|
|
||
|
Diluted
|
71,247,427
|
|
72,274,821
|
|
||
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
Common Stock and Additional Paid-In Capital |
Accumulated Deficit
|
Accumulated Other Comprehensive Loss
|
Total Stockholders’ Equity
|
||||||||||
|
(in millions, except share data)
|
Shares
|
Amount
|
||||||||||||
|
Balance at December 31, 2018
|
70,596,559
|
|
$
|
641
|
|
$
|
(266
|
)
|
$
|
—
|
|
$
|
375
|
|
|
Net income
|
—
|
|
—
|
|
63
|
|
—
|
|
63
|
|
||||
|
Issuance of common stock from restricted stock units and restricted stock awards
|
286,719
|
|
—
|
|
—
|
|
—
|
|
—
|
|
||||
|
Issuance of common stock from exercise of stock options
|
81,282
|
|
1
|
|
—
|
|
—
|
|
1
|
|
||||
|
Stock-based compensation expense
|
—
|
|
9
|
|
—
|
|
—
|
|
9
|
|
||||
|
Repurchase of common stock
|
(782,909
|
)
|
—
|
|
(38
|
)
|
—
|
|
(38
|
)
|
||||
|
Awards effectively repurchased for required employee withholding taxes
|
(101,904
|
)
|
—
|
|
(4
|
)
|
—
|
|
(4
|
)
|
||||
|
Balance at March 31, 2019
|
70,079,747
|
|
$
|
651
|
|
$
|
(245
|
)
|
$
|
—
|
|
$
|
406
|
|
|
|
Common Stock and Additional Paid-In Capital |
Accumulated Deficit
|
Accumulated Other Comprehensive Loss
|
Total Stockholders’ Equity
|
||||||||||
|
(in millions, except share data)
|
Shares
|
Amount
|
||||||||||||
|
Balance at December 31, 2017
|
69,818,392
|
|
$
|
583
|
|
$
|
(377
|
)
|
$
|
—
|
|
$
|
206
|
|
|
Net income
|
—
|
|
—
|
|
54
|
|
—
|
|
54
|
|
||||
|
Other comprehensive income
|
—
|
|
—
|
|
—
|
|
(1
|
)
|
(1
|
)
|
||||
|
Cumulative effect of accounting change
|
—
|
|
—
|
|
3
|
|
—
|
|
3
|
|
||||
|
Issuance of common stock from vested restricted stock units
|
610,266
|
|
—
|
|
—
|
|
—
|
|
—
|
|
||||
|
Issuance of common stock from exercise of stock options
|
206,430
|
|
3
|
|
—
|
|
—
|
|
3
|
|
||||
|
Stock-based compensation expense
|
—
|
|
9
|
|
—
|
|
—
|
|
9
|
|
||||
|
Repurchase of common stock
|
(160,033
|
)
|
—
|
|
(8
|
)
|
—
|
|
(8
|
)
|
||||
|
Awards effectively repurchased for required employee withholding taxes
|
(111,804
|
)
|
—
|
|
(4
|
)
|
—
|
|
(4
|
)
|
||||
|
Balance at March 31, 2018
|
70,363,251
|
|
$
|
595
|
|
$
|
(332
|
)
|
$
|
(1
|
)
|
$
|
262
|
|
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
Three Months Ended March 31,
|
|||
|
(in millions)
|
2019
|
2018
|
||
|
Operating activities
|
|
|
||
|
Net income
|
63
|
|
54
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
||
|
Depreciation and amortization
|
18
|
|
10
|
|
|
Stock-based compensation
|
9
|
|
9
|
|
|
Changes in operating assets and liabilities:
|
|
|
||
|
Accounts receivable
|
1
|
|
13
|
|
|
Unbilled revenue
|
(9
|
)
|
11
|
|
|
Prepaid expenses
|
(12
|
)
|
(11
|
)
|
|
Other assets
|
(30
|
)
|
(24
|
)
|
|
Accounts payable and other current liabilities
|
9
|
|
(15
|
)
|
|
Client deposits
|
(19
|
)
|
(26
|
)
|
|
Accrued wages
|
17
|
|
(15
|
)
|
|
Accrued health insurance costs
|
—
|
|
(1
|
)
|
|
Accrued workers' compensation costs
|
(2
|
)
|
(3
|
)
|
|
Payroll taxes payable and other payroll withholdings
|
(180
|
)
|
(534
|
)
|
|
Operating lease liabilities
|
(4
|
)
|
—
|
|
|
Other liabilities
|
(3
|
)
|
(4
|
)
|
|
Net cash used in operating activities
|
(142
|
)
|
(536
|
)
|
|
Investing activities
|
|
|
||
|
Purchases of marketable securities
|
(30
|
)
|
—
|
|
|
Proceeds from sale and maturity of marketable securities
|
31
|
|
14
|
|
|
Acquisitions of property and equipment
|
(12
|
)
|
(12
|
)
|
|
Net cash (used in) provided by investing activities
|
(11
|
)
|
2
|
|
|
Financing activities
|
|
|
||
|
Repurchase of common stock
|
(38
|
)
|
(8
|
)
|
|
Proceeds from issuance of common stock
|
1
|
|
3
|
|
|
Awards effectively repurchased for required employee withholding taxes
|
(4
|
)
|
(4
|
)
|
|
Repayment of debt
|
(6
|
)
|
(10
|
)
|
|
Net cash used in financing activities
|
(47
|
)
|
(19
|
)
|
|
Net decrease in unrestricted and restricted cash and cash equivalents
|
(200
|
)
|
(553
|
)
|
|
Cash and cash equivalents, unrestricted and restricted:
|
|
|
||
|
Beginning of period
|
1,349
|
|
1,738
|
|
|
End of period
|
1,149
|
|
1,185
|
|
|
|
|
|
||
|
Supplemental disclosures of cash flow information
|
|
|
||
|
Interest paid
|
4
|
|
4
|
|
|
Income taxes paid, net
|
1
|
|
—
|
|
|
Supplemental schedule of noncash investing and financing activities
|
|
|
||
|
Payable for purchase of property and equipment
|
5
|
|
2
|
|
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
•
|
compensation through wages and salaries,
|
|
•
|
employer payroll-related tax payments,
|
|
•
|
employee payroll-related tax withholdings and payments,
|
|
•
|
employee benefit programs, including health and life insurance, and others, and
|
|
•
|
workers' compensation coverage.
|
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
For the Three Months Ended March 31, 2018
|
||||||||
|
(in millions)
|
As previously reported
|
Reclassified amounts
|
As revised
|
||||||
|
Operating activities
|
|
|
|
||||||
|
Changes in operating assets and liabilities:
|
|
|
|
||||||
|
Accounts receivable
|
$
|
—
|
|
$
|
13
|
|
$
|
13
|
|
|
Unbilled revenue
|
—
|
|
11
|
|
11
|
|
|||
|
Prepaid income taxes
|
13
|
|
(13
|
)
|
—
|
|
|||
|
Prepaid expenses and other current assets
|
(9
|
)
|
(2
|
)
|
(11
|
)
|
|||
|
Workers' compensation collateral receivable
|
(1
|
)
|
1
|
|
—
|
|
|||
|
Other assets
|
(2
|
)
|
(22
|
)
|
(24
|
)
|
|||
|
Accounts payable and other current liabilities
|
(15
|
)
|
—
|
|
(15
|
)
|
|||
|
Client deposits
|
—
|
|
(26
|
)
|
(26
|
)
|
|||
|
Accrued wages
|
—
|
|
(15
|
)
|
(15
|
)
|
|||
|
Accrued corporate wages
|
(9
|
)
|
9
|
|
—
|
|
|||
|
Accrued health insurance costs
|
—
|
|
(1
|
)
|
(1
|
)
|
|||
|
Accrued workers' compensation costs
|
—
|
|
(3
|
)
|
(3
|
)
|
|||
|
Workers' compensation loss reserves and other non-current liabilities
|
(6
|
)
|
6
|
|
—
|
|
|||
|
Payroll taxes payable and other payroll withholdings
|
—
|
|
(534
|
)
|
(534
|
)
|
|||
|
Other liabilities
|
—
|
|
(4
|
)
|
(4
|
)
|
|||
|
Worksite employee related assets
|
(14
|
)
|
14
|
|
—
|
|
|||
|
Worksite employee related liabilities
|
(566
|
)
|
566
|
|
—
|
|
|||
|
•
|
liability for unpaid losses and loss adjustment expenses (accrued workers' compensation costs) related to workers' compensation and workers' compensation collateral receivable,
|
|
•
|
accrued health insurance costs,
|
|
•
|
liability for insurance premiums payable,
|
|
•
|
Valuation of the investment portfolio,
|
|
•
|
impairments of goodwill and other intangible assets,
|
|
•
|
income tax assets and liabilities, and
|
|
•
|
liability for legal contingencies.
|
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
•
|
not to reassess 1) whether any contracts that existed prior to adoption have or contain leases, 2) the classification of our existing leases or 3) initial direct costs for existing leases,
|
|
•
|
to use the practical expedient of using hindsight to determine the lease terms and evaluate any impairments in right-of-use assets upon transition, and
|
|
•
|
not separately record non-lease and lease components for all leases in which we act as a lessee.
|
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
|
March 31, 2019
|
||||||||||
|
(in millions)
|
|
As reported
|
|
Balance Using Previous Standard
|
|
Increase (Decrease)
|
||||||
|
Balance sheet
|
|
|
|
|
|
|
||||||
|
Assets
|
|
|
|
|
|
|
||||||
|
Operating lease right-of-use assets
|
|
$
|
59
|
|
|
$
|
—
|
|
|
$
|
59
|
|
|
Liabilities
|
|
|
|
|
|
|
||||||
|
Operating lease liabilities
|
|
16
|
|
|
—
|
|
|
16
|
|
|||
|
Operating lease liabilities, noncurrent
|
|
54
|
|
|
11
|
|
|
43
|
|
|||
|
Equity
|
|
|
|
|
|
|
||||||
|
Accumulated deficit
|
|
$
|
(245
|
)
|
|
$
|
(245
|
)
|
|
$
|
—
|
|
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
March 31, 2019
|
December 31, 2018
|
||||||||||||||||||||||
|
(in millions)
|
Cash and cash equivalents
|
Available-for-sale marketable securities
|
Certificate
of
deposits
|
Total
|
Cash and cash equivalents
|
Available-for-sale marketable securities
|
Certificate
of
deposits
|
Total
|
||||||||||||||||
|
Cash and cash equivalents
|
$
|
251
|
|
$
|
—
|
|
$
|
—
|
|
$
|
251
|
|
$
|
228
|
|
$
|
—
|
|
$
|
—
|
|
$
|
228
|
|
|
Investments
|
—
|
|
56
|
|
—
|
|
56
|
|
—
|
|
54
|
|
—
|
|
54
|
|
||||||||
|
Restricted cash, cash equivalents and investments
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Insurance carriers' security deposits
|
15
|
|
—
|
|
—
|
|
15
|
|
15
|
|
—
|
|
—
|
|
15
|
|
||||||||
|
Payroll funds collected
|
564
|
|
—
|
|
—
|
|
564
|
|
783
|
|
—
|
|
—
|
|
783
|
|
||||||||
|
Collateral for health benefits claims
|
75
|
|
—
|
|
—
|
|
75
|
|
75
|
|
—
|
|
—
|
|
75
|
|
||||||||
|
Collateral for workers' compensation claims
|
65
|
|
1
|
|
—
|
|
66
|
|
66
|
|
1
|
|
—
|
|
67
|
|
||||||||
|
Collateral to secure standby letter of credit
|
—
|
|
—
|
|
2
|
|
2
|
|
—
|
|
—
|
|
2
|
|
2
|
|
||||||||
|
Total restricted cash, cash equivalents and investments
|
719
|
|
1
|
|
2
|
|
722
|
|
939
|
|
1
|
|
2
|
|
942
|
|
||||||||
|
Investments, noncurrent
|
—
|
|
133
|
|
—
|
|
133
|
|
—
|
|
135
|
|
—
|
|
135
|
|
||||||||
|
Restricted cash, cash equivalents and investments, noncurrent
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Collateral for workers' compensation claims
|
179
|
|
5
|
|
—
|
|
184
|
|
182
|
|
5
|
|
—
|
|
187
|
|
||||||||
|
Total
|
$
|
1,149
|
|
$
|
195
|
|
$
|
2
|
|
$
|
1,346
|
|
$
|
1,349
|
|
$
|
195
|
|
$
|
2
|
|
$
|
1,546
|
|
|
|
March 31, 2019
|
December 31, 2018
|
||||||||||||||||||||||
|
(in millions)
|
Amortized Cost
|
Gross Unrealized Gains
|
Gross Unrealized Losses
|
Fair Value
|
Amortized Cost
|
Gross Unrealized Gains
|
Gross Unrealized Losses
|
Fair Value
|
||||||||||||||||
|
Asset-backed securities
|
$
|
35
|
|
$
|
—
|
|
$
|
—
|
|
$
|
35
|
|
$
|
33
|
|
$
|
—
|
|
$
|
—
|
|
$
|
33
|
|
|
Corporate bonds
|
100
|
|
—
|
|
—
|
|
100
|
|
99
|
|
—
|
|
—
|
|
99
|
|
||||||||
|
U.S. government agencies and government-
sponsored agencies
|
6
|
|
—
|
|
—
|
|
6
|
|
7
|
|
—
|
|
—
|
|
7
|
|
||||||||
|
U.S. treasuries
|
47
|
|
—
|
|
—
|
|
47
|
|
46
|
|
—
|
|
—
|
|
46
|
|
||||||||
|
Exchange traded fund
|
1
|
|
—
|
|
—
|
|
1
|
|
1
|
|
—
|
|
—
|
|
1
|
|
||||||||
|
Other debt securities
|
6
|
|
—
|
|
—
|
|
6
|
|
9
|
|
—
|
|
—
|
|
9
|
|
||||||||
|
Total
|
$
|
195
|
|
$
|
—
|
|
$
|
—
|
|
$
|
195
|
|
$
|
195
|
|
$
|
—
|
|
$
|
—
|
|
$
|
195
|
|
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
(in millions)
|
|
March 31, 2019
|
|
||
|
One year or less
|
|
$
|
61
|
|
|
|
Over one year through five years
|
|
117
|
|
|
|
|
Over five years through ten years
|
|
7
|
|
|
|
|
Over ten years
|
|
9
|
|
|
|
|
Total fair value
|
|
$
|
194
|
|
|
|
|
Three Months Ended
March 31, |
|||||
|
(in millions)
|
2019
|
2018
|
||||
|
Gross proceeds from sales
|
$
|
14
|
|
$
|
—
|
|
|
Gross proceeds from maturities
|
17
|
|
14
|
|
||
|
Total
|
$
|
31
|
|
$
|
14
|
|
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
(in millions)
|
March 31, 2019
(2)
|
December 31, 2018
(3)
|
||||
|
2019
(1)
|
$
|
15
|
|
$
|
18
|
|
|
2020
|
17
|
|
17
|
|
||
|
2021
|
10
|
|
11
|
|
||
|
2022
|
8
|
|
9
|
|
||
|
2023
|
8
|
|
8
|
|
||
|
2024
|
5
|
|
5
|
|
||
|
2025 and thereafter
|
19
|
|
20
|
|
||
|
Total future minimum lease payments
|
$
|
82
|
|
$
|
88
|
|
|
Less: imputed interest
|
(12
|
)
|
N/A
(4)
|
|
||
|
Total operating lease liabilities
|
70
|
|
N/A
(4)
|
|
||
|
Current portion
|
16
|
|
N/A
(4)
|
|
||
|
Non-current portion
|
54
|
|
N/A
(4)
|
|
||
|
(2)
|
Presented in accordance with ASC 842, which excludes base payments of
$3 million
for leases that do not yet have a commencement date.
|
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
Three Months Ended
March 31, |
|||||
|
(in millions)
|
2019
|
2018
|
||||
|
Total accrued costs, beginning of period
|
$
|
238
|
|
$
|
255
|
|
|
Incurred
|
|
|
||||
|
Current year
|
19
|
|
20
|
|
||
|
Prior years
|
(5
|
)
|
(7
|
)
|
||
|
Total incurred
|
14
|
|
13
|
|
||
|
Paid
|
|
|
||||
|
Current year
|
(1
|
)
|
—
|
|
||
|
Prior years
|
(15
|
)
|
(18
|
)
|
||
|
Total paid
|
(16
|
)
|
(18
|
)
|
||
|
Total accrued costs, end of period
|
$
|
236
|
|
$
|
250
|
|
|
(in millions)
|
March 31, 2019
|
December 31, 2018
|
||||
|
Total accrued costs, end of period
|
$
|
236
|
|
$
|
238
|
|
|
Collateral paid to carriers and offset against accrued costs
|
(13
|
)
|
(13
|
)
|
||
|
Total accrued costs, net of carrier collateral offset
|
$
|
223
|
|
$
|
225
|
|
|
|
|
|
||||
|
Payable in less than 1 year
(net of collateral paid to carriers of $4 and $3 at March 31, 2019 and December 31, 2018, respectively) |
$
|
67
|
|
$
|
67
|
|
|
Payable in more than 1 year
(net of collateral paid to carriers of $9 and $10 at March 31, 2019 and December 31, 2018, respectively) |
156
|
|
158
|
|
||
|
Total accrued costs, net of carrier collateral offset
|
$
|
223
|
|
$
|
225
|
|
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
RSUs
|
RSAs
|
||||||||
|
|
Number of Units
|
Weighted-Average
Grant Date
Fair Value
|
Number of Units
|
Weighted-Average
Grant Date
Fair Value
|
||||||
|
Nonvested at December 31, 2018
|
1,737,554
|
|
$
|
32.83
|
|
346,792
|
|
$
|
49.13
|
|
|
Granted
|
669,415
|
|
60.43
|
|
—
|
|
—
|
|
||
|
Vested
|
(297,822
|
)
|
28.83
|
|
(13,565
|
)
|
50.48
|
|
||
|
Forfeited
|
(14,908
|
)
|
42.79
|
|
(11,103
|
)
|
49.35
|
|
||
|
Nonvested at March 31, 2019
|
2,094,239
|
|
$
|
42.15
|
|
322,124
|
|
$
|
49.20
|
|
|
|
Three Months Ended March 31,
|
|||||
|
(in millions)
|
2019
|
2018
|
||||
|
Cost of providing services
|
$
|
2
|
|
$
|
2
|
|
|
Sales and marketing
|
1
|
|
2
|
|
||
|
General and administrative
|
5
|
|
4
|
|
||
|
Systems development and programming costs
|
1
|
|
1
|
|
||
|
Total stock-based compensation expense
|
$
|
9
|
|
$
|
9
|
|
|
Income tax benefit related to stock-based compensation expense
|
$
|
3
|
|
$
|
2
|
|
|
Tax benefit realized from stock options exercise and similar awards
|
$
|
2
|
|
$
|
6
|
|
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
Three Months Ended March 31,
|
|||||
|
(in millions, except per share data)
|
2019
|
2018
|
||||
|
Net income
|
$
|
63
|
|
$
|
54
|
|
|
Weighted average shares of common stock outstanding
|
70
|
|
70
|
|
||
|
Basic EPS
|
$
|
0.91
|
|
$
|
0.77
|
|
|
Net income
|
$
|
63
|
|
$
|
54
|
|
|
Weighted average shares of common stock
|
70
|
|
70
|
|
||
|
Dilutive effect of stock options and restricted stock units
|
1
|
|
2
|
|
||
|
Weighted average shares of common stock outstanding
|
71
|
|
72
|
|
||
|
Diluted EPS
|
$
|
0.89
|
|
$
|
0.75
|
|
|
|
|
|
||||
|
Common stock equivalents excluded from income per diluted share because of their anti-dilutive effect
|
1
|
|
1
|
|
||
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
(in millions)
|
Level 1
|
Level 2
|
Total
|
||||||
|
March 31, 2019
|
|
|
|
||||||
|
Cash equivalents:
|
|
|
|
||||||
|
Money market mutual funds
|
$
|
74
|
|
$
|
—
|
|
74
|
|
|
|
U.S. treasuries
|
—
|
|
3
|
|
3
|
|
|||
|
Total cash equivalents
|
74
|
|
3
|
|
77
|
|
|||
|
Investments:
|
|
|
|
||||||
|
Asset-backed securities
|
—
|
|
35
|
|
35
|
|
|||
|
Corporate bonds
|
—
|
|
100
|
|
100
|
|
|||
|
U.S. government agencies and government-sponsored agencies
|
—
|
|
6
|
|
6
|
|
|||
|
U.S. treasuries
|
—
|
|
42
|
|
42
|
|
|||
|
Other debt securities
|
—
|
|
6
|
|
6
|
|
|||
|
Total investments
|
—
|
|
189
|
|
189
|
|
|||
|
Restricted cash equivalents:
|
|
|
|
||||||
|
Money market mutual funds
|
42
|
|
—
|
|
42
|
|
|||
|
Commercial paper
|
19
|
|
—
|
|
19
|
|
|||
|
Total restricted cash equivalents
|
61
|
|
—
|
|
61
|
|
|||
|
Restricted investments:
|
|
|
|
||||||
|
U.S. treasuries
|
—
|
|
5
|
|
5
|
|
|||
|
Exchange traded fund
|
1
|
|
—
|
|
1
|
|
|||
|
Certificate of deposit
|
—
|
|
2
|
|
2
|
|
|||
|
Total restricted investments
|
1
|
|
7
|
|
8
|
|
|||
|
Total unrestricted and restricted cash equivalents and investments
|
$
|
136
|
|
$
|
199
|
|
$
|
335
|
|
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
(in millions)
|
Level 1
|
Level 2
|
Total
|
||||||
|
December 31, 2018
|
|
|
|
||||||
|
Cash equivalents
|
|
|
|
||||||
|
Money market mutual funds
|
$
|
4
|
|
$
|
—
|
|
$
|
4
|
|
|
U.S. treasuries
|
—
|
|
1
|
|
1
|
|
|||
|
Total cash equivalents
|
4
|
|
1
|
|
5
|
|
|||
|
Investments
|
|
|
|
||||||
|
Asset-backed securities
|
—
|
|
33
|
|
33
|
|
|||
|
Corporate bonds
|
—
|
|
99
|
|
99
|
|
|||
|
U.S. government agencies and government-sponsored agencies
|
—
|
|
7
|
|
7
|
|
|||
|
U.S. treasuries
|
—
|
|
41
|
|
41
|
|
|||
|
Other debt securities
|
—
|
|
9
|
|
9
|
|
|||
|
Total investments
|
—
|
|
189
|
|
189
|
|
|||
|
Restricted cash equivalents:
|
|
|
|
||||||
|
Money market mutual funds
|
48
|
|
—
|
|
48
|
|
|||
|
Commercial paper
|
20
|
|
—
|
|
20
|
|
|||
|
Total restricted cash equivalents
|
68
|
|
—
|
|
68
|
|
|||
|
Restricted investments:
|
|
|
|
||||||
|
U.S. treasuries
|
—
|
|
5
|
|
5
|
|
|||
|
Exchange traded fund
|
1
|
|
—
|
|
1
|
|
|||
|
Certificate of deposit
|
—
|
|
2
|
|
2
|
|
|||
|
Total restricted investments
|
1
|
|
7
|
|
8
|
|
|||
|
Total unrestricted and restricted cash equivalents and investments
|
$
|
73
|
|
$
|
197
|
|
$
|
270
|
|
|
|
|
|
|
OTHER INFORMATION
|
|
|
Period
|
Total Number of
Shares
Purchased
(1)
|
|
Weighted Average Price
Paid Per Share |
|
Total Number of
Shares Purchased as Part of Publicly Announced Plans (2) |
|
Approximate Dollar Value ($ millions)
of Shares that May Yet be Purchased Under the Plans (2) |
||||||
|
January 1 - January 31, 2019
|
419,557
|
|
|
$
|
43.29
|
|
|
395,300
|
|
|
$
|
58
|
|
|
February 1 - February 28, 2019
|
354,542
|
|
|
$
|
50.75
|
|
|
277,300
|
|
|
$
|
344
|
|
|
March 1 - March 31, 2019
|
110,714
|
|
|
$
|
61.00
|
|
|
110,309
|
|
|
$
|
337
|
|
|
Total
|
884,813
|
|
|
|
|
|
782,909
|
|
|
|
|||
|
|
|
|
|
OTHER INFORMATION
|
|
|
|
|
|
|
Incorporated by Reference
|
|
|
||||||
|
Exhibit No.
|
|
Exhibit
|
|
Form
|
|
File No.
|
|
Exhibit
|
|
Filing Date
|
|
Filed Herewith
|
|
10.1
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
10.2
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
10.3
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
31.1
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
31.2
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
32.1*
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Linkbase Document
|
|
|
|
|
|
|
|
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
|
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
|
Document has been furnished, is deemed not filed and is not to be incorporated by reference into any of TriNet Group, Inc.’s filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, irrespective of any general incorporation language contained in any such filing.
|
|
|
|
|
|
|
SIGNATURES
|
|
|
|
TRINET GROUP, INC.
|
||
|
|
|
||
|
Date: April 29, 2019
|
|
By:
|
/s/ Burton M. Goldfield
|
|
|
|
|
Burton M. Goldfield
|
|
|
|
|
Chief Executive Officer
|
|
|
|
|
|
|
Date: April 29, 2019
|
|
By:
|
/s/ Richard Beckert
|
|
|
|
|
Richard Beckert
|
|
|
|
|
Chief Financial Officer
|
|
|
|
|
|
|
Date: April 29, 2019
|
|
By:
|
/s/ Michael P. Murphy
|
|
|
|
|
Michael P. Murphy
|
|
|
|
|
Chief Accounting Officer
|
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|